Blood Cell Technologies LLC
Setauket- East Setauket, NY
- UEI
- HH9LT9M9B3N4
- CAGE
- 76LR5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 9 Shipyard Ln, Setauket- East Setauket, NY 11733, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of second generation blvrb inhibitors for treating chemotherapy induced thrombocytopenia - project summary… | National Cancer Institute | $400,000 | |
| Development of a new class of blvrb-targeted redox therapeutics in breast cancer - summary enhanced metabolic and… | National Cancer Institute | $570,400 | |
| Optimization of biliverdin IX? Reductase redox inhibitors as novel reagents for enhancing platelet production -… | National Heart Lung and Blood Institute | $4,214,089 | |
| Detection of fetal platelets in maternal blood using platelet RNA biomarkers. | National Heart Lung and Blood Institute | $272,302 | |
| HLS-detection of RNA biomarkers in individual platelets | National Institute on Aging | $243,104 |
About Blood Cell Technologies LLC
Blood Cell Technologies LLC is a for-profit limited liability company registered in SAM.gov since August 7, 2014, located in Setauket-East Setauket, New York. The company is classified as a self-certified small disadvantaged business focused on developing novel therapeutic compounds targeting metabolic and redox adaptation pathways in cancer and hematologic diseases. Their core research and development efforts are centered on identifying and optimizing small molecule inhibitors that can potentially address critical medical challenges in oncology and hematology.
Through federal grant awards, Blood Cell Technologies LLC has secured multiple project grants from the National Cancer Institute and National Heart Lung and Blood Institute, primarily targeting research in chemotherapy-induced thrombocytopenia and breast cancer treatment. Their grant-funded work involves developing second-generation BLVRB inhibitors to enhance platelet production and exploring redox-targeted therapeutic strategies for cancer treatment. Specifically, their research has included developing small molecule inhibitors of the BLVRB enzyme, conducting in silico modeling to optimize compound potency, evaluating therapeutic ranges in mouse models, and performing safety studies to determine therapeutic indexes. The company has been awarded grants ranging from $400,000 to support targeted research projects with completion dates extending through August 2026, focusing on innovative approaches to cancer treatment and platelet production enhancement through advanced molecular targeting techniques.
Quick answers
What is Blood Cell Technologies LLC's UEI?
Blood Cell Technologies LLC's Unique Entity ID (UEI) in SAM.gov is HH9LT9M9B3N4.
What is Blood Cell Technologies LLC's CAGE code?
Blood Cell Technologies LLC's CAGE code is 76LR5.
What is Blood Cell Technologies LLC's primary NAICS code?
Blood Cell Technologies LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Blood Cell Technologies LLC located?
Blood Cell Technologies LLC's physical address in SAM.gov is 9 Shipyard Ln, Setauket- East Setauket, NY 11733, USA.
Is Blood Cell Technologies LLC registered in SAM.gov?
Yes. Blood Cell Technologies LLC's SAM.gov registration is active through November 20, 2026.
What is Blood Cell Technologies LLC's most recent federal award?
Blood Cell Technologies LLC's most recent federal grant award is Development of second generation blvrb inhibitors for treating chemotherapy induced thrombocytopenia - project summary… (R44CA302180), from National Cancer Institute, on September 1, 2025.
On GovTribe
See Blood Cell Technologies LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors